Genetic Testing Market to grow 10.5% CAGR during the Forecast Period 2022 to 2032

Market Research Future (MRFR) has published a cooked research report on the “Global Genetic Testing Market” that contains information from 2022 to 2030. The Genetic Testing Market is estimated to register a CAGR of 10.5% during the forecast period of 2022 to 2032.

Key Highlights Genetic Testing Market 

The global  Genetic Testing Market is accounted to register a CAGR of 10.5% during the forecast period and is estimated to reach USD 19.8 Billion by 2032.

The term "Genetic Testing Market" refers to the commercial sector and industry involved in the development, distribution, and utilization of genetic tests and related services. Genetic testing involves analyzing an individual's DNA to identify specific genetic variations or mutations that may be associated with certain health conditions, predispositions, ancestry, or other traits.

The Genetic Testing Market has seen significant growth over the years due to advancements in genetic research, technological improvements in DNA sequencing and analysis, and increasing public interest in personalized medicine and genetic insights.

Key Players:

MRFR recognizes the following companies as the key players in the global Genetic Testing Market— PerkinElmer Inc., Myriad Genetics Inc., Abbott Laboratories, Illumina Inc., QIAGEN, Eurofins Scientific, Quest Diagnostics Incorporated, Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc.

Segment Analysis

The global Genetic Testing Market has been segmented based on type and application.

On the basis of type, the market is segmented into molecular genetic tests/dna tests, chromosomal genetic tests and biochemical genetic tests. The segmental expansion will be fueled by the technological superiority of this technique, such as quicker turnaround times and the recent trend of falling next-generation sequencing (NGS) costs.

Based on application, the market has been segmented into reproductive health, cancer screening ancestry and predictive and pre-symptomatic testing. Genetic testing aids in determining a person's lifetime risk of contracting cancer. It achieves this by checking for specific alterations in a person's genes, chromosomes, or proteins.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Genetic Testing Market Research Report

Regional Analysis

The global Genetic Testing Market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Genetic Testing Market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Genetic Testing Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Genetic Testing Market comprises of Middle East, Africa, and Latin America.

The United States and Canada were major players in the Genetic Testing Market. These countries had a well-established healthcare infrastructure, a large number of genetic testing companies, and supportive government policies that fostered the growth of the industry.

Countries within the European Union, such as the United Kingdom, Germany, France, and Spain, were significant contributors to the Genetic Testing Market. The region had a strong emphasis on personalized medicine and genetic research, which drove the adoption of genetic testing services.

The Asia-Pacific region was witnessing rapid growth in the Genetic Testing Market. Factors such as a large population base, increasing healthcare expenditure, and growing awareness of genetic testing's benefits fueled the market expansion.

Furthermore, the rest of the world's Genetic Testing Market is divided into the Middle East, Africa, and Latin America. Countries in Latin America, including Brazil, Mexico, and Argentina, were also experiencing a rise in the adoption of genetic testing services. Improving healthcare infrastructure and rising disposable incomes contributed to market growth in this region.

Key Findings of the Study

• The United States and Canada were major players in the Genetic Testing Market. These countries had a well-established healthcare infrastructure, a large number of genetic testing companies, and supportive government policies that fostered the growth of the industry.


• Based on type, the market is segmented into molecular DNA tests, chromosomal genetic tests and biochemical genetic tests holding the largest market in 2022.


• PerkinElmer Inc., Myriad Genetics Inc., Abbott Laboratories, Illumina Inc., QIAGEN, Eurofins Scientific, Quest Diagnostics Incorporated, Hoffmann-La Roche Ltd and Thermo Fisher Scientific Inc